- Home
- ABOS vs TSVT Comparison
ABOS vs TSVT Comparison
Compare ABOS & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- TSVT
- Stock Information
- Founded
- ABOS 1996
- TSVT 2021
- Country
- ABOS United States
- TSVT United States
- Employees
- ABOS N/A
- TSVT N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- ABOS Health Care
- TSVT Health Care
- Exchange
- ABOS Nasdaq
- TSVT Nasdaq
- Market Cap
- ABOS 138.8M
- TSVT 160.4M
- IPO Year
- ABOS 2021
- TSVT N/A
- Fundamental
- Price
- ABOS $1.92
- TSVT $3.13
- Analyst Decision
- ABOS Strong Buy
- TSVT Buy
- Analyst Count
- ABOS 4
- TSVT 6
- Target Price
- ABOS $9.00
- TSVT $10.40
- AVG Volume (30 Days)
- ABOS 268.9K
- TSVT 245.3K
- Earning Date
- ABOS 11-12-2024
- TSVT 11-12-2024
- Dividend Yield
- ABOS N/A
- TSVT N/A
- EPS Growth
- ABOS N/A
- TSVT N/A
- EPS
- ABOS N/A
- TSVT N/A
- Revenue
- ABOS N/A
- TSVT $45,620,000.00
- Revenue This Year
- ABOS N/A
- TSVT N/A
- Revenue Next Year
- ABOS N/A
- TSVT $36.09
- P/E Ratio
- ABOS N/A
- TSVT N/A
- Revenue Growth
- ABOS N/A
- TSVT N/A
- 52 Week Low
- ABOS $1.91
- TSVT $2.90
- 52 Week High
- ABOS $5.09
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- ABOS 32.44
- TSVT 34.33
- Support Level
- ABOS $1.91
- TSVT $3.17
- Resistance Level
- ABOS $2.03
- TSVT $4.07
- Average True Range (ATR)
- ABOS 0.12
- TSVT 0.22
- MACD
- ABOS -0.02
- TSVT -0.03
- Stochastic Oscillator
- ABOS 6.00
- TSVT 0.62
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.